TacticScaleWhat Bio Rad Laboratories Does & How It Makes Money (BIO)
Updated October 2026 · reflects Bio Rad Laboratories's latest reported financials
Maker of lab research tools and clinical diagnostic tests. It sells instruments along with reagents, consumables, test kits, and quality controls that labs have to keep reordering, plus informatics systems and software.
How Bio Rad Laboratories makes money
It sells instruments along with reagents, consumables, test kits, and quality controls that labs have to keep reordering, plus informatics systems and software. Sales go through its own direct sales team and through distributors, agents, brokers, and resellers.
What Bio Rad Laboratories does
Bio-Rad Laboratories, founded in 1952 and headquartered in Hercules, California, supplies tools for life science research and clinical diagnostics in the United States, Europe, Asia, Canada, Latin America, and other markets. The company has two segments. Life Science sells instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify cells, proteins, and nucleic acids. Its customers include universities, medical schools, government agencies, pharma and biotech companies, food producers, and testing labs. These products are used in research, biopharmaceutical manufacturing, quality control, food safety, and science education. The Clinical Diagnostics segment designs and supports diagnostic test systems, test kits, informatics systems, software, and specialized quality controls. It serves hospital, reference, transfusion, and physician office labs. Bio-Rad sells installed instruments together with consumables that labs reorder, which gives it recurring revenue. It reaches customers through its own direct sales team and through distributors, agents, brokers, and resellers.
Products & services
- Life science research instruments and systems
- Reagents and consumables for protein and nucleic acid analysis
- Biopharmaceutical manufacturing and quality control products
- Clinical diagnostic test systems and test kits
- Specialized quality controls for clinical labs
- Diagnostic informatics systems and software
What is Bio Rad Laboratories worth?
On an owner-earnings DCF, Bio Rad Laboratories's most-likely value is about $277 versus a recent price near $366 (24% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$143) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Bio-Techne (TECH) · Becton, Dickinson and (BDX) · Danaher (DHR) · Thermo Fisher Scientific (TMO) · Autobio Diagnostics (603658.SS)